United States · Federal contract register · Supplier record

MARK CUBAN COST PLUS DRUG COMPANY, PBC

Line: Military; applied research (AC12)Register loaded to July 2026Compiled 6 October 2026

MARK CUBAN COST PLUS DRUG COMPANY, PBC — United States · Federal contract register · Supplier record: 2 contracts, all years ($1,599,179 · Jun 2025 – Apr 2026); $1.6M since January 2024 (2 contracts · 1 agency); 836th rank in the line (of 1,442 suppliers · 0.02%); 3 agencies never served ($360M on the line without MARK CUBAN COST PLUS DRUG COMPANY, PBC).

Assay record ASY-US-12E4TQN0M7 · Cite as: Assay Systems, “MARK CUBAN COST PLUS DRUG COMPANY, PBC in the USAspending register”, https://assay-systems.com/register/us/mark-cuban-cost-plus-drug-company-pbc/

2
contracts, all years
$1,599,179 · Jun 2025 – Apr 2026
$1.6M
since January 2024
2 contracts · 1 agency
836th
rank in the line
of 1,442 suppliers · 0.02%
3
agencies never served
$360M on the line without MARK CUBAN COST PLUS DRUG COMPANY, PBC

Own record by year

2025 onward
$206K
$1.4M
20252026

Who buys from MARK CUBAN COST PLUS DRUG COMPANY, PBC

since January 2024
1agencies
$1.6Mpaid
100.0%top buyer
Department of Defense100.0%
$1,599,179

The line

since January 2024
$6.2Bline value
2,910contracts
4agencies
1,442suppliers
23.2%held by top ten

Military; applied research (AC12)

$3.4B
$2.0B
$786M
202420252026Jan–Jul
836thof 1,442 suppliers
$1,393,259MARK CUBAN COST PLUS DRUG COMPANY, PBC in the line
0.02%share of the line
0.0%of $5,854,302,483 spent by Department of Defense

Agencies that buy the line and never bought from MARK CUBAN COST PLUS DRUG COMPANY, PBC

3agencies
38contracts
$359,997,672since January 2024
General Services Administration23 contracts
$344,453,067
Department of the Interior6 contracts
$14,267,316
Department of Homeland Security9 contracts
$1,277,289

How the line is bought

by value, since 2024
24%no competition
18%one applicant
0of these to MARK CUBAN COST PLUS DRUG COMPANY, PBC
Competed, several suppliers applied2,161 contracts
$3,633,157,403 · 58.5%
Awarded directly, no competition270 contracts
$1,473,025,528 · 23.7%
Competed, one supplier applied479 contracts
$1,108,117,224 · 17.8%

Contracts reaching their end dates

Oct 2026 – October 2027
1,049contracts
$2,859,755,942end by October 2027
116end in October 2026 · $215M
20in agencies never served · $330M
$215M
$193M
$390M
$183M
$209M
$216M
$169M
$162M
$242M
$190M
$198M
$456M
$37.6M
Oct 26116 contractsNov 2682 contractsDec 2686 contractsJan 2776 contractsFeb 2758 contractsMar 2797 contractsApr 2783 contractsMay 2775 contractsJun 2776 contractsJul 2781 contractsAug 2793 contractsSep 27103 contractsOct 2723 contracts

Suppliers next to it in the line

since January 2024
GEOCENTRIC TECHNOLOGIES LLC1 contract · 1 agency
$1,395,468
HOOD TECHNOLOGY CORP1 contract · 1 agency
$1,394,853
MARK CUBAN COST PLUS DRUG COMPANY, PBC
$1,393,259
RENAISSANCE SERVICES INC1 contract · 1 agency
$1,390,291

All 1,442 suppliers in the line

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.